Descrizione

Acne is a common skin condition causing pimples and other abnormalities on the face and upper torso. Acne is caused by an interaction between hormones, skin oils, and bacteria, which results in inflammation of hair follicles (the pores in the skin where hair grows). The global acne medication market is set to grow by US$ 2 miliardi durante 2021-2027, crescendo ad un tasso di crescita annuale composto (CAGR) Di 5.2% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix. Increasing sedentary lifestyle and unhealthy food habits, increasing prevalence of acne and facial skin diseases, rise in adoption of skin care products, growing acne cases in geriatric population are expected to boost the market growth in the coming years.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2017-2020 e previsione a 2027 covering key market aspects like sales value for acne medication. The global acne medication market is segmented on the basis of therapeutic class, route of administration, tipo, e regione. By therapeutic class, it is categorized into retinoids, antibiotics, hormonal agents, e altri. The retinoids segment held the largest market share in 2020. By route of administration, the acne medication market is divided into topical, and oral. The topical segment accounted for the largest market share in 2020. Based on type, the acne medication market is divided into prescription medicine, and over-the-counter (OTC) medicine.

The report has profiled some of the key players of the market such as Allergan plc, Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestlé SA), GlaxoSmithKline Plc (GSK), Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd..

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the acne medication market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Therapeutic class: retinoids, antibiotics, hormonal agents, e altri
Route of administration: topical, and oral
Tipo: prescription medicine, and over-the-counter (OTC) medicine
Regione: Nord America, Asia Pacifico, Europa, and Rest of the World (ROW)
Anni considerati: la presente relazione copre il periodo 2017 A 2027

Principali vantaggi per gli stakeholder

Get a comprehensive picture of the global acne medication market
Identificare le strategie regionali e le priorità strategiche sulla base di dati e analisi locali
Individuare i settori in crescita e le tendenze per gli investimenti
Understand what the future of the global acne medication market looks like
Identificare il panorama competitivo e la finestra di opportunità

Sommario

1. Definizione del mercato
2. Metodologia di ricerca
3. Dati di mercato & Veduta
3.1 Valore di mercato
3.2 Previsione del valore di mercato
4. Acne Medication Market by Therapeutic Class
4.1 Retinoids
4.2 Antibiotics
4.3 Hormonal Agents
4.4 Altri
5. Acne Medication Market by Route Of Administration
5.1 Topical
5.2 Oral
6. Acne Medication Market by Type
6.1 Prescription Medicine
6.2 Over-The-Counter (Otc) Medicine
7. Acne Medication Market by Region
7.1 Nord America
7.2 Asia Pacifico
7.3 Europa
7.4 Rest Of The World (Row)
8. Profili aziendali
8.1 Allergan plc
8.2 Bausch Health Companies Inc.
8.3 F. Hoffmann-la Roche Ltd.
8.4 Galderma S.A. (Nestlé SA)
8.5 GlaxoSmithKline Plc (GSK)
8.6 Mylan N.V.
8.7 Perrigo Company plc
8.8 Pfizer Inc.
8.9 Teva Pharmaceutical Industries Ltd.
9. Appendice
9.1 Informazioni su StrategyHelix
9.2 Disclaimer